These projected Ultrio Plus ID-NAT based prevalence rates were then used by ratio modelling to estimate TT-HBV risk per million in eight infection stages using the infectivity conversion factors calculated by the Weusten models [4,10] in Table 1. Here, BRD2 is linked to infection.